Utah Medical Products Inc (UTMD)
EBITDA Growth
-36.92%
Quarterly · Period ending:
UTMD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-36.92%period ending
Latest reported-36.92%period ending
UTMD Quarterly EBITDA YoY % (47.06% → -36.92%)
Year-over-year change
High-resolution chart · PNG
UTMD ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 6.1521% | |
| 11.3107% | |
| -4.9756% | |
| -3.75% | |
| 7.28% | |
| 6.4783% | |
| 10.5385% | |
| 16.6667% | |
| 25% | |
| 21.0526% | |
| 30% | |
| 9.0909% | |
| 42.8571% | |
| 35.7143% | |
| -39.3939% | |
| -38.8889% | |
| -60% | |
| -54.8387% | |
| -8.3333% | |
| 5.8824% | |
| 6.0606% | |
| 3.3333% | |
| 24.1379% | |
| 17.2414% | |
| 17.8571% | |
| 11.1111% | |
| 61.1111% | |
| 7.4074% | |
| -3.4483% | |
| 8% | |
| -30.7692% | |
| -12.9032% | |
| 20.8333% | |
| 13.6364% | |
| 4% | |
| 29.1667% | |
| 26.3158% | |
| 29.4118% | |
| 31.5789% | |
| 26.3158% | |
| 11.7647% | |
| 41.6667% | |
| 18.75% | |
| 46.1538% | |
| 112.5% | |
| -68.4211% | |
| 122.8571% | |
| -62.8571% | |
| -73.3333% | |
| 52% | |
| -52.1739% | |
| 84.2105% | |
| 76.4706% | |
| 47.0588% |